Novocure Ltd (NVCR) vs Zenas BioPharma, Inc. (ZBIO)
A side-by-side comparison of Novocure Ltd and Zenas BioPharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NVCR
Novocure Ltd
$14.97HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ZBIO
Zenas BioPharma, Inc.
$26.94HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NVCR vs ZBIO
growth of $100 · dividends reinvested · last 2yNVCR -15.4% (-8.0%/yr)ZBIO +54.9% (+24.4%/yr)ZBIO compounded faster over this window
NVCR ZBIO
NVCR vs ZBIO: by the numbers
- •NVCR is the larger company ($1.74B vs $1.70B market cap).
- •Both run net losses; NVCR's is the smaller (-21.25% vs -48438.40% net margin).
Metrics side by side
Valuation
| Metric | NVCR | ZBIO |
|---|---|---|
| P/S ratio | 2.49 | 1700.81 |
| P/B ratio | 5.16 | 6.88 |
Profitability
| Metric | NVCR | ZBIO |
|---|---|---|
| Gross margin | 76.13% | 100.00% |
| Operating margin | -22.08% | -2113.85% |
| Net margin | -21.25% | -48438.40% |
| ROE | -43.94% | -196.03% |
| ROIC | -26.88% | -74.69% |
Growth (annualized)
| Metric | NVCR | ZBIO |
|---|---|---|
| Revenue CAGR (5Y) | 5.12% | N/A |
| Total return CAGR (5Y) | -32.71% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.